SNX 2112 | PF-04928473
SNX-2112 (Synonyms: PF-04928473)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
5 mg 10 mg 50 mg
Product Availability
3-5days
Price
$166.00
Member price
Product Availability
3-5days
Price
$246.00
Member price
Product Availability
3-5days
Price
$666.00
Member price
Quantity
- +
Product Overview
Product Name SNX-2112 (Synonyms: PF-04928473)
CAS908112-43-6
FormulaC23H27F3N4O3
MW464.48
AppearanceWhite to off-white powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

 SNX-2112, also known as PF 04928473, is an Hsp90 inhibitor which is currently undergoing multiple phase 1 clinical trials. In all cell lines, SNX-2112 led to degradation of MET, HER-2, EGFR, and AKT as well as abrogation of Ras/Raf/MEK/MAPK and PI3K/AKT signaling, followed by complete cell cycle arrest.

Related
Sorry, no related items
History
Z-DEVD-FMK | Caspase-3 Inhibitor
Milciclib | PHA-848125
SNX-2112 (Synonyms: PF-04928473)
Fmoc-Lys(AC)-OH
Saracatinib (AZD0530)
Levobupivacaine Base (Synonyms: (S)-(-)-Bupivacaine)
Bictegravir (Synonyms: GS-9883)
Trabectedin (Synonyms: Ecteinascidin 743; ET-743)
cis-ent-Tadalafil/Tadalafil EP impurity C
STING agonist-4